0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Devices Reimbursement Market by Payer Outlook, Device Type, Device Classification, Application, End-User - Global Forecast to 2030- Product Image
Medical Devices Reimbursement Market by Payer Outlook, Device Type, Device Classification, Application, End-User - Global Forecast to 2030- Product Image
Sale

Medical Devices Reimbursement Market by Payer Outlook, Device Type, Device Classification, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666289
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Medical Devices Reimbursement Market grew from USD 574.80 billion in 2024 to USD 618.25 billion in 2025. It is expected to continue growing at a CAGR of 7.73%, reaching USD 898.78 billion by 2030.

Setting the Stage for Reimbursement Dynamics

The medical devices reimbursement landscape has evolved into a complex tapestry of regulatory rigor, payer policies, and technological innovation. In recent years, stakeholders across the value chain have navigated an increasingly fragmented environment, where public and private payers apply divergent coverage criteria and pricing frameworks. This dynamic has heightened the need for device manufacturers, healthcare providers, and policy advocates to adopt a more integrated approach to reimbursement strategy. Technological advancements-from next-generation imaging modalities to minimally invasive therapeutic platforms-have placed upward pressure on cost structures, even as payers demand quantifiable evidence of clinical and economic value. At the same time, globalization of supply chains and geopolitical considerations have injected new uncertainty into cost forecasting and market access. As we transition into 2025, the confluence of evolving payer demands, regulatory recalibrations, and market entry barriers underscores the imperative for stakeholders to refine their strategic playbook. This introduction sets the stage for a deep dive into the transformative shifts reshaping reimbursement pathways, the tariff recalibrations altering cost dynamics, and the granular segmentation insights that underpin competitive advantage.

Catalytic Forces Redefining Reimbursement Frameworks

A new era of reimbursement is unfolding, characterized by a convergence of value-based care initiatives and digital health integration. Payers are increasingly prioritizing outcomes over volume, leveraging real-world evidence and risk-sharing agreements to align payments with patient benefit. This shift has prompted device developers to invest in post-market studies and generate longitudinal data demonstrating both clinical efficacy and cost-effectiveness. Concurrently, artificial intelligence and remote monitoring technologies are redefining care delivery, enabling earlier interventions and personalized treatment pathways. These innovations have compelled payers to reassess traditional fee-for-service models and explore bundled payment arrangements for procedural and episodic care. On the regulatory front, agencies are streamlining approval processes for breakthrough devices, yet intensifying scrutiny on demonstration of value. As a result, market access strategies are evolving from pre-market clearance to continuous evidence generation. These catalytic forces are reshaping the reimbursement framework, driving stakeholders to adopt more agile, data-driven approaches. In the sections ahead, we will explore how the interplay of these dynamics is creating both opportunity and complexity for the industry at large.

Tariff Implications Transforming Cost Structures in 2025

The introduction of United States tariffs in 2025 has reverberated across the medical devices sector, fundamentally altering cost structures and market dynamics. Tariffs on imported components and finished devices have elevated manufacturing expenses, prompting domestic producers to reevaluate supply chain strategies. Many manufacturers have accelerated localization efforts, forging new partnerships with regional suppliers to mitigate tariff exposure. However, this shift has also triggered capital reallocation, as investments in production facilities and quality systems become prerequisites for maintaining compliance and market competitiveness. Payers, in turn, are grappling with price adjustments and contract renegotiations to absorb the downstream impact of these heightened input costs. These negotiations are often protracted, underscoring the tension between cost containment goals and the imperative to ensure clinician access to innovative technologies. Simultaneously, the tariff environment has catalyzed strategic alliances among device makers, distributors, and providers aiming to share risk and streamline procurement pathways. As stakeholders adapt to this new tariff reality, robust cost-profile analyses and scenario-planning exercises are emerging as critical tools for sustaining market access and preserving margins.

Dissecting Market Segments to Reveal Growth Drivers

Insight into market segmentation reveals the differential drivers of growth and reimbursement complexity across payer categories, device types, classifications, applications, and end-user channels. Private payers often exhibit greater agility in adopting value-based arrangements, incentivizing device innovations that demonstrate rapid patient benefit, whereas public programs impose more standardized price controls and rigorous coverage determinations. The spectrum of device types-from consumables and disposables through advanced imaging systems to therapeutic platforms-reveals distinct evidentiary requirements and utilization trends. Within classification tiers, lower-risk devices encounter streamlined pathways but face intensified price competition, while higher-risk, class III devices demand extensive clinical trials and post-market surveillance before securing favorable reimbursement status. Applications spanning cardiology, neurology, oncology, and orthopedics each present unique adoption curves and budgetary pressures, driven by the prevalence of chronic conditions and procedural volumes. At the point of care, hospitals and clinics represent the most concentrated reimbursement arena, with outpatient and inpatient channels subject to separate reimbursement codes and cost structures. Ambulatory surgical centers and home healthcare settings are increasingly significant, reflecting the broader shift toward decentralized care. This granular lens on segmentation underscores the necessity for bespoke market access strategies aligned to each unique combination of payer, device, indication, and care setting.

Regional Variances Shaping Reimbursement Outcomes

Regional dynamics play a pivotal role in shaping reimbursement pathways and competitive intensity within the medical devices market. In the Americas, a complex mosaic of federal and state regulations, coupled with a dual private-public insurance model, drives both innovation incentives and cost containment measures. Stakeholders here must navigate a highly fragmented payer landscape where evidence thresholds and contracting approaches vary significantly. In Europe, Middle East & Africa, region-wide harmonization efforts coexist with localized pricing and reimbursement processes, requiring tailored submissions to national health technology assessment bodies. Policymakers are emphasizing cross-border data sharing to optimize resource allocation and patient access, yet cost pressures remain acute. Across Asia-Pacific, rapid economic development and burgeoning healthcare infrastructure investment are expanding device adoption, even as emerging markets implement evolving reimbursement frameworks that balance access and fiscal sustainability. Regional procurement consortia and volume-based contracting are gaining traction, underscoring the importance of scale and local partnerships. A nuanced understanding of these geographic nuances is essential for manufacturers seeking to align market entry timing, evidence generation plans, and pricing strategies with region-specific requirements.

Competitive Insights from Leading Medical Device Players

Leading medical device enterprises are deploying differentiated strategies to secure reimbursement and sustain growth in a competitive environment. Some are forging value-based partnerships with payers, sharing performance risk in exchange for expedited market access and premium pricing. Others are investing in integrated care solutions that bundle devices with digital therapeutics and service offerings, positioning themselves as strategic partners in population health management. Strategic acquisitions and alliances are also prevalent, enabling companies to expand their product portfolios and geographic reach while leveraging established distribution channels. Many innovators are focusing on modular platforms that can be rapidly adapted to multiple clinical indications, thereby optimizing R&D spend and accelerating time to market. To address payer scrutiny, these leading players are constructing robust real-world evidence programs, establishing data registries, and publishing outcomes studies in peer-reviewed journals. This evidence-driven approach not only supports reimbursement negotiations but also fosters clinician adoption and brand credibility. Taken together, these competitive maneuvers illustrate a fundamental shift from purely product-centric models toward partnerships that embed devices within broader healthcare ecosystems.

Strategic Imperatives for Industry Stakeholders

Industry leaders must navigate an increasingly intricate landscape by embracing strategies that align clinical value with economic sustainability. First, developing adaptive evidence generation frameworks-not confined to pre-market trials but extending into post-market real-world studies-will be crucial for demonstrating sustained patient benefit and justifying premium pricing. Second, engaging payers early through joint clinical programs and risk-sharing pilots can expedite coverage decisions and mitigate reimbursement delays. Third, diversifying supply chains and exploring nearshoring initiatives will help cushion the impact of tariff volatility and reduce lead times. Fourth, integrating digital health solutions into device offerings can create differentiated value propositions that resonate with value-based care models. Fifth, forming consortiums with healthcare providers and patient advocacy groups can facilitate collaborative care pathways and strengthen negotiating positions with payers. By implementing these imperatives, stakeholders can transform reimbursement challenges into strategic advantages, ensure resilient market access, and drive sustainable long-term growth.

Rigorous Methodology Underpinning Market Insights

This research employs a multi-method approach combining primary interviews with senior executives across device manufacturers, payers, and provider networks, alongside secondary data analysis from regulatory filings, industry publications, and health economics journals. Proprietary data sets on pricing trends and reimbursement code utilization were analyzed using advanced statistical techniques to identify patterns and correlations. Scenario planning workshops involving subject matter experts modeled the effects of tariff adjustments and policy changes on cost structures and adoption rates. Additionally, case studies of exemplar reimbursement pathways were developed to illustrate best-practice strategies and common pitfalls. Data triangulation ensured that findings reflect both the quantitative rigor and qualitative depth necessary for actionable insights. Strict quality control measures-including peer review and validation against external benchmarks-were applied to guarantee accuracy and reliability. This comprehensive methodology underpins the conclusions and recommendations presented, offering stakeholders confidence in the strategic guidance provided.

Converging Insights to Chart Future Trajectories

The convergence of evolving reimbursement models, tariff recalibrations, and segmentation complexities has created a landscape in which strategic foresight is paramount. As payers shift toward outcome-based frameworks, device innovators must align development and evidence generation with clearly defined value propositions. Tariff pressures demand supply chain agility and cost-profiling sophistication. Granular segmentation analysis underscores the necessity of tailored market access strategies that account for payer type, device classification, clinical application, and care setting. Regional nuances further complicate go-to-market planning, requiring localized approaches to pricing and health technology assessments. Competitive insights highlight the move from standalone products to integrated solutions within broader care ecosystems. Taken together, these dynamics signal that success will hinge on the ability to synthesize clinical, economic, and operational levers into cohesive reimbursement strategies. By embracing adaptive evidence frameworks, risk-sharing collaborations, and supply chain resilience, stakeholders can turn these challenges into strategic differentiators and secure enduring value in a fast-evolving environment.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Payer Outlook
    • Private
    • Public
  • Device Type
    • Consumables and Disposables
      • Syringes & Needles
      • Wound Care Products
    • Diagnostic Imaging Equipment
      • Computed Tomography (CT) Scanners
      • Magnetic Resonance Imaging (MRI) Equipment
      • Ultrasound Devices
      • X-Ray Systems
    • Mobility Aids
    • Therapeutic Devices
      • Dialysis Equipment
      • Infusion Systems
      • Respiratory Therapy Devices
        • Oxygen Therapy Equipment
        • Ventilators
  • Device Classification
    • Class I
    • Class II
    • Class III
  • Application
    • Cardiology
      • Cardiac Rhythm Management
      • Interventional Cardiology Devices
    • Neurology
      • Cerebrospinal Fluid Management
      • Neurostimulation Devices
    • Oncology
      • Chemotherapy Administration
      • Radiation Therapy Equipment
    • Orthopedics
      • Joint Reconstruction
      • Spinal Surgery Devices
  • End-User
    • Ambulatory Surgical Centers
    • Home Healthcare
    • Hospitals & Clinics
      • In-patient Care
      • Out-patient Care
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • AiM GmbH
  • Allianz SE
  • Anco Insurance
  • Anthem Insurance Companies, Inc.
  • Aviva PLC
  • BNP Paribas
  • CVS Health Corporation
  • European Med Tech and IVD Reimbursement Consulting Ltd.
  • Hamilton Leigh Ltd.
  • HUB International Limited
  • Humana Inc.
  • MCRA, LLC
  • mdiConsultants, Inc.
  • Medmarc Insurance Group
  • North American Science Associates, Inc.
  • Reliance Nippon Life Insurance Company
  • UnitedHealth Group
  • UnitedHealth Group Incorporated
  • WellCare Health Plans, Inc.
  • WS Value & Dossier GmbH
  • XIFIN, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Medical Devices Reimbursement Market, by Payer Outlook
8.1. Introduction
8.2. Private
8.3. Public
9. Medical Devices Reimbursement Market, by Device Type
9.1. Introduction
9.2. Consumables and Disposables
9.2.1. Syringes & Needles
9.2.2. Wound Care Products
9.3. Diagnostic Imaging Equipment
9.3.1. Computed Tomography (CT) Scanners
9.3.2. Magnetic Resonance Imaging (MRI) Equipment
9.3.3. Ultrasound Devices
9.3.4. X-Ray Systems
9.4. Mobility Aids
9.5. Therapeutic Devices
9.5.1. Dialysis Equipment
9.5.2. Infusion Systems
9.5.3. Respiratory Therapy Devices
9.5.3.1. Oxygen Therapy Equipment
9.5.3.2. Ventilators
10. Medical Devices Reimbursement Market, by Device Classification
10.1. Introduction
10.2. Class I
10.3. Class II
10.4. Class III
11. Medical Devices Reimbursement Market, by Application
11.1. Introduction
11.2. Cardiology
11.2.1. Cardiac Rhythm Management
11.2.2. Interventional Cardiology Devices
11.3. Neurology
11.3.1. Cerebrospinal Fluid Management
11.3.2. Neurostimulation Devices
11.4. Oncology
11.4.1. Chemotherapy Administration
11.4.2. Radiation Therapy Equipment
11.5. Orthopedics
11.5.1. Joint Reconstruction
11.5.2. Spinal Surgery Devices
12. Medical Devices Reimbursement Market, by End-User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Home Healthcare
12.4. Hospitals & Clinics
12.4.1. In-patient Care
12.4.2. Out-patient Care
13. Americas Medical Devices Reimbursement Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Medical Devices Reimbursement Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Medical Devices Reimbursement Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AiM GmbH
16.3.2. Allianz SE
16.3.3. Anco Insurance
16.3.4. Anthem Insurance Companies, Inc.
16.3.5. Aviva PLC
16.3.6. BNP Paribas
16.3.7. CVS Health Corporation
16.3.8. European Med Tech and IVD Reimbursement Consulting Ltd.
16.3.9. Hamilton Leigh Ltd.
16.3.10. HUB International Limited
16.3.11. Humana Inc.
16.3.12. MCRA, LLC
16.3.13. mdiConsultants, Inc.
16.3.14. Medmarc Insurance Group
16.3.15. North American Science Associates, Inc.
16.3.16. Reliance Nippon Life Insurance Company
16.3.17. UnitedHealth Group
16.3.18. UnitedHealth Group Incorporated
16.3.19. WellCare Health Plans, Inc.
16.3.20. WS Value & Dossier GmbH
16.3.21. XIFIN, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MEDICAL DEVICES REIMBURSEMENT MARKET MULTI-CURRENCY
FIGURE 2. MEDICAL DEVICES REIMBURSEMENT MARKET MULTI-LANGUAGE
FIGURE 3. MEDICAL DEVICES REIMBURSEMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. MEDICAL DEVICES REIMBURSEMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. MEDICAL DEVICES REIMBURSEMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MEDICAL DEVICES REIMBURSEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY SYRINGES & NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY WOUND CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY X-RAY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY MOBILITY AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIALYSIS EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY INFUSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY OXYGEN THERAPY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CLASS I, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CLASS II, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CLASS III, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROSTIMULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CHEMOTHERAPY ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RADIATION THERAPY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY SPINAL SURGERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY IN-PATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY OUT-PATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 87. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 88. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 89. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 90. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 91. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 92. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 93. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 94. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 96. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 97. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 98. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 99. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 102. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 104. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 105. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 106. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 107. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 108. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 110. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 111. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 112. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 172. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 173. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 174. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 175. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 176. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 177. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 178. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 179. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 181. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 182. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 183. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 184. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 186. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 187. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 188. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 189. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 190. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 191. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 192. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 193. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 195. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 196. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 197. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 198. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 214. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 215. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 216. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 217. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 218. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 219. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 220. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 221. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 223. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 224. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 225. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 226. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 228. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 229. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 230. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 231. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 232. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 233. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 234. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 235. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 237. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 238. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 239. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 240. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 256. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 258. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 262. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 270. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 272. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 284. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
TABLE 285. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 286. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 287. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 288. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 289. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 290. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 291. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 293. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 294. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 295. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 296. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 297. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLO

Companies Mentioned

The companies profiled in this Medical Devices Reimbursement market report include:
  • AiM GmbH
  • Allianz SE
  • Anco Insurance
  • Anthem Insurance Companies, Inc.
  • Aviva PLC
  • BNP Paribas
  • CVS Health Corporation
  • European Med Tech and IVD Reimbursement Consulting Ltd.
  • Hamilton Leigh Ltd.
  • HUB International Limited
  • Humana Inc.
  • MCRA, LLC
  • mdiConsultants, Inc.
  • Medmarc Insurance Group
  • North American Science Associates, Inc.
  • Reliance Nippon Life Insurance Company
  • UnitedHealth Group
  • UnitedHealth Group Incorporated
  • WellCare Health Plans, Inc.
  • WS Value & Dossier GmbH
  • XIFIN, Inc.

Methodology

Methodology DOWNLOAD NOW

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 618.25 Billion
Forecasted Market Value ( USD ) by 2030 $ 898.78 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Medical Devices Industry: Competitive Landscape - Product Image

Medical Devices Industry: Competitive Landscape

  • Report
  • 213 Pages
  • Global
From
EUR$3,255USDGBP
EUR$4,650USDGBP
US Medical Devices Market Outlook to 2027 - Product Image

US Medical Devices Market Outlook to 2027

  • Report
  • 80 Pages
  • United States
From
EUR$4,850USDGBP
Asia-Pacific (APAC) Medical Devices Industry Outlook 2023 - Product Image

Asia-Pacific (APAC) Medical Devices Industry Outlook 2023

  • Report
  • 66 Pages
  • Asia Pacific
From
EUR$4,950USDGBP
Medical Devices - Industry Report - Product Image

Medical Devices - Industry Report

  • Report
  • 1129 Pages
  • Global
From
EUR$1,331USDGBP
Refurbished Medical Equipment Market by Product Type, Condition of Equipment, Distribution Channel, Applications, End-Users - Global Forecast to 2030 - Product Image

Refurbished Medical Equipment Market by Product Type, Condition of Equipment, Distribution Channel, Applications, End-Users - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more